p14ARF mutants do not bind C1QBP

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Several cancer-derived missense mutations in the CDKN2A gene result in substitution of arginine residues in the C-terminal arginine-rich region of p14ARF ( CDKN2A-4). p14ARF mutants p14ARF R81G, p14ARF R82C, p14ARF R87C, p14ARF R88Q, p14ARF R90H, p14ARF R98Q, p14ARF R99C and p14ARF R98L;R99S are unable to bind to C1QBP (p32) and they do not localize to mitochondria. Binding of these mutants to other p14ARF interacting proteins, such as MDM2 and NPM1 (B23), remains unaffected. Mutations in p14ARF that affect binding to C1QBP interfere with p53-mediated apoptosis (Itahana and Zhang 2008).
Missense mutations affecting arginine residue R98 have also been reported to affect p14ARF localization to nucleolus and to diminish, due to partial mislocalization, the ability of p14ARF to sequester MDM2 (Zhang et al. 1999).

Literature References
PubMed ID Title Journal Year
18538737 Mitochondrial p32 is a critical mediator of ARF-induced apoptosis

Itahana, K, Zhang, Y

Cancer Cell 2008
Participant Of
Normal reaction
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Cite Us!